Publications by authors named "Michael Mattern"

Claim this Profile
T
The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's Disease.
Kumar Suresh, Michael Mattern, Matthew S Goldberg, Tauseef R Butt

Neuromolecular Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b.
Leilani M Chirino, Suresh Kumar, Mariko Okumura, David E Sterner, Michael Mattern

Eur J Immunol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Ubiquitin Binders to Decipher the Ubiquitin Code.
Michael Mattern, James Sutherland, Karteek Kadimisetty, Rosa Barrio, Manuel S Rodriguez

Trends Biochem Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.
Jian Wu, Suresh Kumar, Feng Wang, Hui Wang, Lijia Chen, Michael Mattern

J Med Chem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60.
Feng Wang, Liqing Wang, Jian Wu, Ivan Sokirniy, Phuong Nguyen, Michael Mattern

PLoS One· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spiral phase mask shadow-imaging for 3D-measurement of flow fields.
Martin Teich, Michael Mattern, Jeremy Sturm, Lars Büttner, Jürgen W Czarske

Opt Express· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive ubiquitin E2 profiling of ten ubiquitin E3 ligases.
Jeffrey G Marblestone, Samir Butt, Devin M McKelvey, David E Sterner, Michael R Mattern

Cell Biochem Biophys· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin-based anticancer therapy: carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors.
Michael R Mattern, Jian Wu, Benjamin Nicholson

Biochim Biophys Acta· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteins.
Jeffrey G Marblestone, James P Larocque, Michael R Mattern, Craig A Leach

Biochim Biophys Acta· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47.
Joseph Weinstock, Jian Wu, Ping Cao, William D Kingsbury, Jeffrey L McDermott, Michael R Mattern

ACS Med Chem Lett· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy.
Michael J Eddins, Jeffrey G Marblestone, K G Suresh Kumar, Craig A Leach, David E Sterner, Michael R Mattern

Cell Biochem Biophys· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format.
Xufan Tian, Nigora S Isamiddinova, Raymond J Peroutka, Seth J Goldenberg, Michael R Mattern

Assay Drug Dev Technol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approach for characterizing ubiquitin E3 ligase function.
Jeffrey G Marblestone, K G Suresh Kumar, Michael J Eddins, Craig A Leach, David E Sterner, Michael R Mattern

J Biomol Screen· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for the identification of ubiquitin ligase inhibitors.
Seth J Goldenberg, Jeffrey G Marblestone, Michael R Mattern, Benjamin Nicholson

Biochem Soc Trans· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and characterization of SUMO protease activity using a sensitive enzyme-based reporter assay.
Craig A Leach, Xufan Tian, Michael R Mattern, Benjamin Nicholson

Methods Mol Biol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for the identification of novel inhibitors of deubiquitinating enzymes.
Seth J Goldenberg, Jeffrey L McDermott, Tauseef R Butt, Michael R Mattern, Benjamin Nicholson

Biochem Soc Trans· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities.
Benjamin Nicholson, Craig A Leach, Seth J Goldenberg, Dana M Francis, Matthew P Kodrasov, Michael R Mattern

Protein Sci· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
Joseph P Marino, Paul W Fisher, Glenn A Hofmann, Robert B Kirkpatrick, Cheryl A Janson, Michael Mattern

J Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deubiquitinating enzymes as novel anticancer targets.
Benjamin Nicholson, Jeffrey G Marblestone, Tauseef R Butt, Michael R Mattern

Future Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced expression and purification of membrane proteins by SUMO fusion in Escherichia coli.
Xun Zuo, Shuisen Li, John Hall, Michael R Mattern, Hiep Tran

J Struct Funct Genomics· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small ubiquitin-like modifying protein isopeptidase assay based on poliovirus RNA polymerase activity.
Jamie J Arnold, Alejandro Bernal, Uzo Uche, David E Sterner, Tauseef R Butt, Michael R Mattern

Anal Biochem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUMO fusion technology for difficult-to-express proteins.
Tauseef R Butt, Suzanne C Edavettal, John P Hall, Michael R Mattern

Protein Expr Purif· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.
Lara S Kallander, Qing Lu, Wenfang Chen, Thaddeus Tomaszek, Guang Yang, Michael R Mattern

J Med Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and purification of SARS coronavirus proteins using SUMO-fusions.
Xun Zuo, Michael R Mattern, Robin Tan, Shuisen Li, John Hall

Protein Expr Purif· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins.
Michael P Malakhov, Michael R Mattern, Oxana A Malakhova, Mark Drinker, Stephen D Weeks

J Struct Funct Genomics· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis